Status:

WITHDRAWN

Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborating Sponsors:

TAP Pharmaceutical Products Inc.

Conditions:

Head and Neck Cancer

Oropharyngeal Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this clinical research study is to learn if radiation-induced xerostomia \[RIX\] (dry mouth) causes, or worsens the effects of, acid reflux (heartburn and heartburn-like symptoms) in head ...

Detailed Description

The Study Drug: Dexlansoprazole is designed to block the production of excess stomach acid that is the cause of acid reflux disease. Study Groups: If you are found to be eligible to take part in th...

Eligibility Criteria

Inclusion

  • Signed informed consent.
  • Head and neck cancer (HNC) Oropharynx cancer (OPC) patients who are adults \> 18 years of age, dispositioned to receive curative RT with bilateral neck (including) parotid irradiation with or without chemotherapy.
  • Radiation Therapy (3D conformal or IMRT).

Exclusion

  • Subjects unable to tolerate pH-probe in past.
  • Subjects currently on proton-pump inhibitor (PPI), daily antacids and daily H2 antagonists.
  • Prior history of esophago-gastric surgery.
  • Symptoms of active gastrointestinal bleeding (melena, hematemesis).
  • Known hepatic cirrhosis or esophageal varices.
  • Prior esophageal perforation.
  • Pregnant or lactating woman. Women of childbearing potential who have not undergone a hysterectomy with either a positive or no pregnancy test at baseline. Women / men of childbearing potential not using a reliable and appropriate contraceptive method (oral, injectable, or implantable hormonal contraceptive; tubal ligation; intra-uterine device; barrier contraceptive with spermicide; or vasectomized partner).
  • Subjects with allergies or sensitivities to proton-pump inhibitors.
  • Patients who cannot complete study follow-up and compliance with study protocol.
  • Patients on Plavix (if medically appropriate)

Key Trial Info

Start Date :

November 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00928161

Start Date

November 1 2012

Last Update

September 7 2012

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.